search
Home  /  Products  /  Thermal Therapy  /  Tempro  /  Clinical Data  /  
TEMPRO BIPOLAR RADIO FREQUENCY FOR CHRONIC PROSTATITIS

World Congress of Endourology, Oct. 2009, Germany


ABSTRACT
Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CPPS) is a clinical entity not easy to diagnose and treat. Inflammation / infection of the Prostate may be present and hence the rationale to use a Thermotherapy Treatment. We have used a Bipolar Radio Frequency Treatment (Tempro-by Direx Group) and report here the results of the first 60 Patients after 1 year follow up. Patients in categories NIH II and III A benefited from the treatment whereas patients in NIH category III B failed. Considering that CPPS is a very challenging illness, even a 43% success rate should be cconsidered very encouraging and justifies additional larger, in depth studies to evaluate the potential of this treatment.

TABLE 1   Patients Demographics                                                                                                                             

Characteristics

Value
# of the patients 60
Mean age (range) 42 years(range 28-57)
Mean prostate size(cc) 40 cc
NIH classification (%)  
Category II 20 (33.33%)
Category IIIA 40 (66.66%)
Category III B Stopped treating
Most bothersome symptoms  
Pelvic pain (%) 20 (33.33%)
20 (33.33%)  
Perineal and/orperianal pain (%) 18 (30%)

Orchalgia (%)

10 (16.66%)

 

                                                           Table 2

Taking a Criteria of Improvement as a 50% Reduction in Symptoms Score

at 12 Months

 

Baseline CPSI Score Post-TEMPRO CPSI Score
Mean Total score 23.1 16.3(30%)
Mean paindomain score 11.7 6.9(41%)
Mean Quality of life domain score 6.7 4.7(30%)
Overall result(> = 50%) YES = 26(43%)

NO =34(57%)

 

   

 

 

 

 

 

 

 

INTRODUCTION
Introduction Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a major health care burden we find in our daily urological practice. Several conservative types of treatments are available but many patients are not relieved of their painful symptoms for long periods of time. Therefore, we started a trial using the Tempro system (Direx-Initia) to treat Chronic Prostatitis on our patients. We are here reporting our initial results with patients that have completed at least a 12 months follow.


MATERIAL AND METHODS
We used the Radiofrequency Thermal Treatment with a treatment protocol of 53.5 degrees Celsius for 60 minutes. All patients had symptoms at least 3 to 6 months, and have tried different drugs, such as Ciprofloxacin, Tamsulosine and NSAID, without success. The way to analyze quantitatively the potential improvement, was using the NIH Symptoms Score. Patient demographics and most bothersome symptoms can be seen in Table 1.

RESULTS
The results after 12 months are seen in Table Acute complications were: 4 UTI treated with Antibiotics, 2 ''de novo'' voiding symptoms with Conservative management and 3 Urinary retentions, treated with indwelling catheters for 3-5 days.

CONCLUSION
Considering that Chronic Prostatitis is a challenging illness, these initial results, with an overall success rate of 43% are very encouraging. Perineal and/or perianal pain, as well as orchalgia, are substantially improved in the majority of the patients.
The Tempro treatments it is a simple, safe and effective procedure with minimal side effects. Longer follow up and a larger trial is required to explore in depth the potential of this treatment.

 





Additional News:
TEMPRO Bipolar RF Thermal Treatment for Abacterial Chronic Prostatitis
Clinical Experience with Direx Tempro System in the Treatment of the Lower Urinary Tract Symptoms, Following BPH Using Radio Frequency
Initial Experience with Tempro Treatment for BPH Patients in Italy
A New Transurethral Bipolar Radio Frequency Device for BPH Thermal Treatment One Year Follow Up
Initial Experience With Tempro A Novel Thermal Treatment For BPH